Kyle Samani of Pristine thought that the OR was the best place to introduce Google Glass to the healthcare system. His presentation at DEMO last fall involved a blood-squirting dummy on an operating table and won the company a God award.
Good press is nice, but revenue is better. The company announced Monday that it is partnering with select Wound Care Advantage centers to bring Pristine EyeSight to patient care. The EyeSight software securely streams real-time audio and video from Google Glass to authorized iOS devices, Android devices, Macs and PCs. With the Glass headset, nurses will have both hands for patient care while doing a video consult.
“Wound Care Advantage and Pristine have created an approach to successfully meet HIPAA compliance, improve the patient experience and conquer wound care from a distance, with Google Glass,” said Kurt Arisohn, COO of Wound Care Advantage.
Making telemedicine easier will help providers get care to patients more quickly.
“The longer it takes to get a patient to appropriate experts, the higher the likelihood that the wound can become either life threatening or require an amputation,” said Mike Comer, CEO of Wound Care Advantage. “Pristine’s Google Glass app, EyeSight, goes a long way to helping WCA enable better outcomes.”
In an email yesterday, Samani quoted an IT director from Would Care Advantage who helped with the rollout of EyeSight:
“You all came out and it just worked. I’ve seen smoke and mirrors, but your presentation was superb. I can tell when I’m being sold smoke and mirrors. But it just worked. You guys came out and said it, and then did it, instead of selling it. It was awesome.”
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Samani said that the company’s development and training teams will be working with WCA to roll out EyeSight across WCA’s client base.
[Image of wounded foot being bandaged from BigStock]
